feed,title,long_url,short_url
Benzinga,"Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades",https://benzinga.com/analyst-ratings/analyst-color/24/01/36723304/aclaris-therapeutics-ati-1777-faces-uphill-battle-in-atopic-dermatitis-treatment-la,https://da.gd/e3zWSB
Benzinga,Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study,https://benzinga.com/analyst-ratings/analyst-color/24/01/36723287/rare-disease-focused-ionis-pharmaceuticals-gears-up-for-fda-submission-after-donida,https://da.gd/79aZ5q
